|
PAK1IP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.970600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.816900E-03 |
| Normal-vs-Stage2 |
1.101150E-01 |
| Normal-vs-Stage3 |
4.800300E-04 |
| Normal-vs-Stage4 |
4.87230000001393E-06 |
| Stage1-vs-Stage2 |
4.898200E-01 |
| Stage1-vs-Stage3 |
1.235350E-01 |
| Stage1-vs-Stage4 |
1.734290E-02 |
| Stage2-vs-Stage3 |
1.170200E-01 |
| Stage2-vs-Stage4 |
1.658230E-02 |
| Stage3-vs-Stage4 |
3.052600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.187100E-04 |
| Normal-vs-AfricanAmerican |
6.979200E-04 |
| Normal-vs-Asian |
1.589040E-01 |
| Caucasian-vs-AfricanAmerican |
2.189800E-01 |
| Caucasian-vs-Asian |
1.257570E-01 |
| AfricanAmerican-vs-Asian |
3.206500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.429300E-04 |
| Normal-vs-Female |
2.322300E-03 |
| Male-vs-Female |
2.054400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.277700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.152200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.442640E-03 |
| Normal-vs-Age(81-100Yrs) |
9.625800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.139400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.181200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.089800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.746400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.037590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.239390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.837400E-01 |
| Classical-VS-Follicular |
2.744000E-01 |
| Classical-VS-Other |
1.327570E-01 |
| Classical-VS-Normal |
6.781600E-03 |
| Tall-VS-Follicular |
9.842000E-01 |
| Tall-VS-Other |
3.593400E-01 |
| Tall-VS-Normal |
9.642900E-03 |
| Follicular-VS-Other |
4.036000E-01 |
| Follicular-VS-Normal |
3.177300E-03 |
| Other-VS-Normal |
1.869520E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.161100E-04 |
| Normal-vs-N1 |
2.034000E-04 |
| N0-vs-N1 |
1.719040E-01 |
|
|
